Risk Benefit Assessment of Ethinylestradiol Using a Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach
Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1085
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 27, 2018
Authors
Publisher
Wiley